Levetiracetam Impuirty B

Levetiracetam Impurity B is a structurally related synthetic byproduct arising from the formation of a 1,3-oxazine ring in place of the thiazine core in the parent drug. Its structure features a substituted acetamide moiety linked to a saturated five-membered heterocycle containing an oxygen atom at the 1,3-position, differing from Levetiracetam’s sulfur-containing thiazine ring. This impurity results from a side reaction during ring closure, where oxygen incorporation competes with sulfur. The compound exhibits a rigid, planar conformation due to the oxazine ring’s conjugation with the acetamide group. It serves as a critical HPLC reference standard for quantifying process-related impurities in Levetiracetam bulk drug substance synthesis.